Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remaxol in Malignant Mechanical Jaundice
NCT03416062Phase 3Completed
- Sponsor
- POLYSAN
- Start
- Apr 2017
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Remaxol in obstructive jaundice, sponsored by POLYSAN. Started Apr 2017; status: completed.
02
Drugs
Remaxol
03
Conditions
obstructive jaundice
Beyond the preview
Go deeper on NCT03416062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416062.